ArticleAmerican journal of translational research2025
Clinical efficacy and psychological benefits of combination therapy in elderly patients with hypertension.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the effects of different antihypertensive agents on psychiatric symptoms and blood pressure control in elderly patients with hypertension.
methodsThis retrospective study included 300 elderly patients with hypertension. Patients were categorized based on their antihypertensive medication regimen: divided into the monotherapy group (n=70) and combination therapy group (n=230), with each further subdivided by medication type. The monotherapy group comprised angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) (n=10), calcium channel blockers (CCBs) (n=33), β-blockers (β-Bs) (n=22), and diuretic (n=5) subgroups. The combination therapy group included ACEIs/ARBs + diuretic (n=12), CCBs + diuretic (n=9), β-Bs + diuretic (n=21), ACEIs/ARBs + CCBs (n=36), CCBs + β-Bs (n=69), ACEIs/ARBs + β-Bs (n=26), and ACEIs/ARBs + β-Bs + CCBs (n=57) subgroups. Blood pressure, anxiety, depression, and sleep quality were evaluated before and after 8 weeks of treatment. Multivariate logistic regression was used to identify factors associated with poor treatment efficacy.
resultsThe Combination therapy group achieved superior blood pressure control compared with the monotherapy group (75.65% vs. 47.14%). Both the ACEIs/ARBs and the ACEIs/ARBs + CCBs groups had significantly improved anxiety, depression, and sleep quality (all P<0.05). In contrast, the β-Bs and β-Bs + diuretics groups had aggravated psychiatric symptoms. The incidence of adverse events was comparable among groups (all P>0.05). After adjustment for confounding factors, combination therapy remained a protective factor for treatment efficacy (P<0.05).
conclusionCombination therapy is more effective for blood pressure control in elderly patients with hypertension. ACEIs/ARBs, alone or combined with CCBs, alleviate psychiatric symptoms, whereas β-blockers, especially when combined with diuretics may exacerbate them. The efficacy advantage of combination therapy is independent of potential confounders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.